External Device for Erectile Dysfunction (3D-Erect)

Last updated: January 12, 2026
Sponsor: Stanford University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Impotence

Erectile Dysfunction

Infertility

Treatment

3D-Erect

Clinical Study ID

NCT04624126
IRB-57222
  • Ages > 18
  • Male

Study Summary

The aim of this clinical trial is to test the safety and feasibility of a non-invasive 3D-printed external penile device to achieve successful and satisfactory sexual intercourse in men with erectile dysfunction (ED).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • males >18 years old suffering from any cause moderate to severe erectile dysfunction (e.g. ED after radical prostatectomy and/or radiation therapy for prostate cancerand or other pelvic malignancies affecting the sexual potency; emotional andpsychological ED; organic vascular and/or metabolic ED etc.)

  • having a female partner willing to participate in the study.

Exclusion

Exclusion Criteria:

  • not willing to attempt sexual vaginal intercourse with their partner

  • inability to wear/operate the external penile device for any reason

Study Design

Total Participants: 9
Treatment Group(s): 1
Primary Treatment: 3D-Erect
Phase:
Study Start date:
July 10, 2021
Estimated Completion Date:
December 31, 2026

Study Description

A clinical trial to test the safety and feasibility of our newly developed non-invasive 3D-printed external penile device for the treatment and recovery of erectile dysfunction.

Connect with a study center

  • Stanford Health Care, Stanford Hospital

    Stanford, California 94305
    United States

    Site Not Available

  • Stanford Health Care, Stanford Hospital

    Stanford 5398563, California 5332921 94305
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.